Navigation Links
International consortium to examine the impact of medical devices on health and retirement
Date:1/5/2011

WASHINGTON, DCThe Institute for Health Technology Studies (InHealth) has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).

Hip replacement has been shown to improve quality of life by restoring physical mobility and reducing pain. However, there is evidence that a substantial number of patients who might benefit from the procedure do not receive it. Currently, between 200,000 and 300,000 hip replacement procedures are performed in the United States each year. But in the 2002 U.S. Health and Retirement Study, nearly 50% of retired respondents ages 55 to 64 reported arthritis and other musculoskeletal conditions as the most significant reasons they could no longer work.

Early retirement triggered by such conditions is a contributing factor to the current financial crises of Europe's pension systems and of the U.S. Social Security trust fund, which is projected to be exhausted by 2037. Under their grant from InHealth, the consortium's researchers aim to generate evidence on whether hip replacement can enable people with debilitating musculoskeletal conditionsincluding severe pain, osteoarthritis, and rheumatoid arthritisto continue working, consequently easing the financial pressure on these critical retirement systems.

"Industrialized nations around the world are trying to accommodate the mounting cost pressure that their aging populations place on limited public and healthcare resources," says Martyn Howgill, InHealth's executive director. "InHealth's grant will help assess the impact of reduced disabilities made possible by hip replacements on public and private retirement funds."

Howgill adds that this is the first time InHealth has awarded a grant to academic institutions outside the United States.

For the study, researchers will examine economic and sociodemographic factors that contribute to an individual's decision about receiving a hip replacement. Data sources for the study will include the English Longitudinal Study of Aging; the Survey of Health, Aging, and Retirement in Europe; and the U.S. Health and Retirement Study. The three sources collect similar financial and other patient information, including current and prospective pension payments; employment; health conditions; physical health; healthcare interventions; and sociodemographic characteristics of individuals 50 years of age or older and their partners.

Investigators will then compare patients who received a hip replacement with those who did not, to determine how the treatment affected their employment and retirement decisions. Based on this comparative data, they will estimate the impact of hip replacement on national pension and Social Security systems, and the potential outcome of financial incentivessuch as tax breaksthat could encourage working adults to delay retirement.

"We chose to study hip replacement in continental Europe, England, and the United States because of the country variations in incentives for retirement and the number of older adults still in the work force," says Ruben Mujica-Mota, PhD, a senior research fellow at the Center for Research in Healthcare Management at the Universit Bocconi and lead investigator for the study. "We aim to contribute evidence to the growing debate in these countries over policy measures to reduce the gap between available tax revenues and the public expenditures required to provide Social Security and pension benefits."

The consortium conducting the study, "The Effect of Medical Devices on Health and Retirement: The Case of Hip Replacement Therapy," was drawn together by the European Health Technology Institute for Socio-Economic Research (Brussels), an independent research institute aimed at developing data and evidence on the social and economic value of medical technology and its impact on the economy and welfare of European countries.


'/>"/>

Contact: Caitlin Hool
caitlin.hool@gabbe.com
212-220-4444
InHealth: The Institute for Health Technology Studies
Source:Eurekalert

Related medicine news :

1. New international conference in bionic engineering
2. International clinical trial tests targeted drug for melanoma
3. Experts present new testing methods at international meeting in New Orleans, Nov. 14-18
4. Half of those travelling internationally not aware of potential health risks
5. From cholera to blindness, experts present cutting-edge research at international meeting
6. International summit held to stimulate collaborative clinical research on antiphospholipid syndrome
7. International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women
8. Boston, Oct. 21-24: Largest international pediatric oncology conference
9. International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health
10. International Robotic Urology Symposium+2011
11. Medical profession needs special training to handle self-harm, says international review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... ... 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC introduce a ... solid foundation. As experts in dangerous situations the Inflow IQ team can help ... deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017  The goal of the ... identify and track prescription drugs as they are distributed ... response to requirements from US FDA to better protect ... dangerous medicines. Blockchain startup Chronicled, which ... chips and blockchain technology and recently raised $6.25M, and ...
(Date:3/23/2017)... 2017 The global reprocessed ... the top five players accounting for nearly 94% ... are Stryker Sustainability Solutions, Ethicon (Johnson & Johnson), ... VANGUARD AG. Despite the high level of consolidation, ... the prevalence of fierce competition among the key ...
(Date:3/23/2017)... -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) today ... Phase 1 study of MM-310 in solid tumors. MM-310 ... taxane and targets the EphA2 receptor, a protein which ... tumor types, including prostate, ovarian, bladder, gastric, pancreatic and ... is an important step in evaluating MM-310,s safety and ...
Breaking Medicine Technology: